Boston Scientific expects 2026 organic revenue growth of 5%-6% and outlines $500M run-rate savings exiting 2029

EarningsPositive

AI Analysis

Boston Scientific projects 5%-6% organic revenue growth for 2026 and outlines plans to achieve $500M in run-rate cost savings by the end of 2029.

Guidance

5%-6% organic revenue growth in 2026; $500M run-rate savings exiting 2029

Importance:4/10

Sentiment:

0.50

guidancecost savingsrevenue outlook

Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 29, 2026 4:04 PM